WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: EXFORGE HCT

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on EXFORGE HCT

Proof of use for EXFORGE HCT

We do not have any records of a proof of use for EXFORGE HCT at this moment.

Click here to add a proof of use for EXFORGE HCT

Possible trademark infringements of EXFORGE HCT

Basic Information about EXFORGE HCT

Serial Number
77202989
Filing Date
11 Jun 2007
Registration Number
3923438
Registration Date
22 Feb 2011
Mark Drawing Code
4

Classifications

Declare the trademark use of EXFORGE HCT on the blockchain with WikiTrademarks.io.

First use of EXFORGE HCT anywhere
EXFORGE HCT was first used on 31 May 2009 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
005
US Codes
006; 018; 044; 046; 051; 052

Who owns EXFORGE HCT?

1. Novartis AG Basel

2. Novartis AG Basel

3. Novartis AG Basel

Correspondent

Maury M. Tepper, III
TEPPER & EYSTER, PLLC
3724 BENSON DR
RALEIGH NC 27609

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on EXFORGE HCT